Skip to main content
Fig. 10 | Alzheimer's Research & Therapy

Fig. 10

From: A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro

Fig. 10

ISAD1 and ISAD1rev reduce toxic effects of intracellularly expressed TauRDΔK aggregates. Expression of TauRDΔK in N2a cells was induced by adding 1 μg/ml doxycycline. The cells were incubated with different concentrations of ISAD1 and ISAD1rev (25, 50, 100, 250 μM) for 24 h at 37 °C followed by determination of MTT and LDH intensities. A Peptides prevent intracellular toxic Tau effects by preserving metabolic activity from 100 μM concentration (blue and red bars) similar to untreated cells (gray bar, UT -Dox) [n = 2; one-way ANOVA with Tukey’s post hoc test; F(11, 60) = 126; ***p ≤ 0.001]. B Protection of cell membrane integrity by D-peptides (blue and red bars) determined by LDH release [n = 2; one-way ANOVA with Tukey’s post hoc test; F(11, 60) = 256; ***p ≤ 0.001].

Back to article page